Norges Bank’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$990K Buy
+31,405
New +$990K ﹤0.01% 1547
2025
Q1
Sell
-125,551
Closed -$4.54M 1474
2024
Q4
$4.54M Buy
+125,551
New +$4.54M ﹤0.01% 1523
2024
Q3
Sell
-208,835
Closed -$5.59M 1542
2024
Q2
$5.59M Sell
208,835
-23,410
-10% -$626K ﹤0.01% 1532
2024
Q1
$7.92M Sell
232,245
-42,895
-16% -$1.46M ﹤0.01% 1518
2023
Q4
$7.96M Sell
275,140
-22,148
-7% -$641K ﹤0.01% 1567
2023
Q3
$8.2M Sell
297,288
-43,359
-13% -$1.2M ﹤0.01% 1542
2023
Q2
$10.2M Sell
340,647
-16,453
-5% -$495K ﹤0.01% 1521
2023
Q1
$12.9M Sell
357,100
-71,473
-17% -$2.59M ﹤0.01% 1474
2022
Q4
$15.3M Hold
428,573
﹤0.01% 1395
2022
Q3
$14.5M Hold
428,573
﹤0.01% 1375
2022
Q2
$12.4M Sell
428,573
-46,561
-10% -$1.35M ﹤0.01% 1457
2022
Q1
$15.4M Sell
475,134
-20,179
-4% -$652K ﹤0.01% 1521
2021
Q4
$14.4M Buy
495,313
+54,663
+12% +$1.59M ﹤0.01% 1614
2021
Q3
$11.8M Buy
440,650
+26,887
+6% +$717K ﹤0.01% 1713
2021
Q2
$12.7M Sell
413,763
-71,916
-15% -$2.21M ﹤0.01% 1708
2021
Q1
$12.7M Sell
485,679
-45,249
-9% -$1.18M ﹤0.01% 1717
2020
Q4
$13.4M Sell
530,928
-50,966
-9% -$1.28M ﹤0.01% 1695
2020
Q3
$12.1M Sell
581,894
-53,226
-8% -$1.11M ﹤0.01% 1645
2020
Q2
$15.1M Sell
635,120
-63,427
-9% -$1.51M ﹤0.01% 1593
2020
Q1
$12.6M Hold
698,547
﹤0.01% 1503
2019
Q4
$16.6M Hold
698,547
﹤0.01% 1618
2019
Q3
$19.2M Sell
698,547
-31,298
-4% -$860K 0.01% 1502
2019
Q2
$24.2M Hold
729,845
0.01% 1384
2019
Q1
$25.6M Sell
729,845
-14,000
-2% -$491K 0.01% 1334
2018
Q4
$24.7M Hold
743,845
0.01% 1249
2018
Q3
$37.5M Hold
743,845
0.01% 1085
2018
Q2
$44.5M Buy
743,845
+81,436
+12% +$4.87M 0.02% 924
2018
Q1
$30.3M Buy
662,409
+75,818
+13% +$3.47M 0.01% 1140
2017
Q4
$23.4M Buy
586,591
+185,398
+46% +$7.39M 0.01% 1370
2017
Q3
$16M Buy
+401,193
New +$16M 0.01% 1558